Active Ingredient History
Bone marrow examination refers to the pathologic analysis of samples of bone marrow obtained by bone marrow biopsy and bone marrow aspiration. Bone marrow examination is used in the diagnosis of a number of conditions, including leukemia, multiple myeloma, lymphoma, anemia, and pancytopenia. The bone marrow produces the cellular elements of the blood, including platelets, red blood cells and white blood cells. While much information can be gleaned by testing the blood itself, it is sometimes necessary to examine the source of the blood cells in the bone marrow to obtain more information on hematopoiesis; this is the role of bone marrow aspiration and biopsy. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 3)
Anemia, Sickle Cell (Phase 2)
Autoimmune Diseases (Phase 2)
Bone Marrow Transplantation (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Bronchiectasis (Phase 2)
Burkitt Lymphoma (Phase 3)
Cardiomyopathy, Dilated (Phase 2)
Cerebellar Diseases (Phase 2)
Craniofacial Abnormalities (Phase 2)
Encephalitis (Phase 2)
Epidermolysis Bullosa (Phase 2)
Facial Injuries (Phase 2)
Facial Transplantation (Phase 2)
Fanconi Anemia (Phase 2/Phase 3)
Fractures, Ununited (Phase 1/Phase 2)
Fusion Proteins, bcr-abl (Phase 2)
Graft Survival (Phase 2)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 2)
Heart Failure (Phase 2)
Hematologic Diseases (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 3)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Kidney Transplantation (Phase 2)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Liver Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Myasthenia Gravis (Phase 2)
Myeloablative Agonists (Phase 2)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Neuromyelitis Optica (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Organ Transplantation (Phase 2)
Osteoarthritis (Phase 2/Phase 3)
Osteogenesis Imperfecta (Phase 1)
Osteopetrosis (Phase 2/Phase 3)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Pseudarthrosis (Phase 1/Phase 2)
Retinoblastoma (Phase 2)
Sarcoma (Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Sclerosis (Phase 1/Phase 2)
Severe Combined Immunodeficiency (Phase 1/Phase 2)
Spinal Fusion (Phase 4)
Stiff-Person Syndrome (Phase 2)
Testicular Neoplasms (Phase 2)
Traumatology (Phase 2)
Ulcer (Phase 1)
Vasculitis, Central Nervous System (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
